Royalty Report: Drugs, Proteins, Assay – Collection: 233480

$100.00

Curated Royalty Rate Report
Category: Technology Licenses, Created On: 2022-04-28, Record Count: 3

Description

This collection of transactions and supporting information was developed using our AI algorithm to curate similar royalty reports into a cohesive collection to support your licensing, transfer pricing or other transaction scenarios where documented royalty rates and/or deal terms are important.
Category: Technology Licenses
Created On: 2022-04-28
Record Count: 3

Primary Industries

  • Drugs
  • Proteins
  • Assay
  • Diagnostic
  • Disease
  • Drug Discovery

IPSCIO Report Record List

Below you will find the records curated into this collection.  This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs.  The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms.  For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report

IPSCIO Record ID: 233480

License Grant
For the Co~Exclusive License to Licensee in the Non-Commercial Field, Licensor grants a co-exclusive, non-transferable worldwide license under the Licensor patents and technology to make and sell fluorescent products in the Licensee Non~Commercial Field for the Term.

For the Co-Exclusive License to Licensee in the Commercial Field, Licensor grants a co-exclusive, non-transferable worldwide license under the Licensor patents and technology to make and sell fluorescent products in the Licensee Commercial Field for the Term.

For the Non-exclusive License to Licensee in the Non-Commercial Field  Licensor grants a non-exclusive, non-transferable, worldwide license under the Licensor patents and technology to make and sell fluorescent products in the Licensee Non~Commercial Field for the Term.

For the Non-exclusive License, Licensor grants a non-exclusive, non-transferable, worldwide license under the Licensor patents and technology to make and sell fluorescent products internally at Licensee for discovering and developing new research reagents.

For the Non-exclusive License, Licensor grants a non-exclusive, non-transferable, worldwide license under the Licensor patents and technology to have fluorescent products made by third party for Licensees sale of fluorescent products.

License Property
The patents are relating to certain fluorescent protein technology.

Fluorescent Product means the following items sold on or after the effective date  1) cell-free, biochemical reagents and  2) cell lines wherein (1) and (2) either contain polynucleotides encoding mutant Aequorea victoria  fluorescent proteins or mutant Aequorea victoria fluorescent proteins used as molecular weight markers,  Annexin-V fusion proteins or mutant Aequorea victoria fluorescent proteins as kinase or protease sensors.

For clarity, the term Fluorescent Product excludes fusion proteins made of Targets or analogs thereof, or antibodies or similar functioning proteins.

Field of Use
Licensee Non-Commercial Field means biochemical reagent catalog and internet sales of  1) cell-free, biochemical reagent to for-profit organizations and not-for-profit organizations for a Non-Commercial Purpose; and  2) cell line sales to for profit organizations and not-for-profit organizations for a Non-Commercial Purpose.

Licensee Commercial Field means for Commercial use by third parties that have been granted an express license by Licensor.

IPSCIO Record ID: 203482

License Grant
Licensor hereby grants to Licensee a non-exclusive, non-transferable license under the Licensor Patents to make, use and import Licensor Mutant GFP and Improvements made by Licensor during the License Period in the Territory for use in the Field during the License Period.

Licensor hereby grants to Licensee a non-exclusive, non-transferable license under the Stanford Patents to make, use and import Licensor Mutant GFP and Improvements made by Licensor during the License Period in the Territory for use in the Field during the License Period.

Licensor hereby grants to Licensee a non-exclusive,  non-transferable license to make, use and import the Licensor Technology and Improvements made by Licensor during the License Period in the Territory for use in the Field during the License Period.

License Property
Licensor Patents means the patents and patent applications listed, and incorporated herein by reference, and any continuations, divisions, reissues, extensions or continuations-in-part with respect thereto, and all United States patents issuing therefrom.

5,625,048 – Modified green fluorescent proteins
6,066,476 – Modified green fluorescent proteins
5,777,079 – Modified green fluorescent proteins
6,054,321 – Long wavelength engineered fluorescent proteins

Licensor Mutant GFP means any mutant Aequorea Victoria fluorescent protein, or any polynucleotide encoding any mutant Aequorea Victoria fluorescent protein, which is covered by the Licensor Patents or the Stanford Patents, and which is (i) supplied by Licensor, (ii) supplied by a bona fide licensee of Licensor licensed under the Licensor Patents or the Stanford Patents to sell Licesor Mutant GFP, or (iii) internally developed by Licensee.

Stanford Patents means the U.S. patents and applications listed, and incorporated herein by reference, and continuations, divisions, reissues, extensions or continuations-in-part with respect thereto, and all United States patents issuing there from.

5,968,738 – Two-reporter FACS analysis of mammalian cells using green fluorescent proteins
5,804,387 – FACS-optimized mutants of the green fluorescent protein (GFP)

Licensor Technology means any of the polynucleotides listed, hereto and incorporated herein by reference, and Licensors proprietary technical manual for use of the same.

1.
2 ug of cDNA encoding the emerald mutant clone
2.
2 ug of cDNA encoding the Sapphire mutant clone
3.
2 ug of cDNA encoding the Topaz mutant clone
4.
2 ug of cDNA encoding the W1B mutant clone
5.
2 ug of cDNA encoding the P43 mutant clone

Licensor Product means (i) any small molecule compound, or analog or derivative thereof, which is identified, developed or discovered by Licensor as active against a Licensee Target using an Licensor Assay, and pursued and developed for that Licensee Target, or (ii) any small molecule compound, or analog or derivative thereof, that is determined by Licensor using Confidential Information of Licensee disclosed to Licensor under the Collaboration to affect the activity of (1) an OSP Receptor, or (2) an OSP/OSP Receptor pair.

Field of Use
This agreement pertains to the drug industry which Field means internal use of Licensor Mutant GFP (I) to perform Cytoplasmic staining, including using vectors containing IRES constructs to determine transfection efficiency, and (ii) to create fusion proteins for basic research (e.g., tagging individual proteins).

Licensor will use its proprietary CellSensorTM Panel on Licensee's behalf to identify proteins of interest as potential therapeutics.

IPSCIO Record ID: 282914

License Grant
Licensor grants a nonexclusive, worldwide license under Licensor Copyrights, Licensor Patent Rights and Licensor Technology to develop, use and make Collaborative Screens with Licensor Reporters for Internal Research, and develop, use and make Licensee Screens with Licensor Reporters for Internal Research, and use the Licensees ultra-high throughput screening systems, or UHTSS, for Internal Research.
License Property
Licensor has expertise in the development of automated ultra-high throughput screening systems and screening biologies/chemistries used therein.

The patents are Fluorogenic Substrates for Beta-Lactamase and Their Use in Assaying Reporter Gene Expression, Protein Localization, and Bacterial Resistance;  Modified Green Fluorescent Proteins;  Tandem Fluorescent Protein Constructs;  Assays For Protein Kinases Using Fluorescent Protein Substrates;  Voltage Sensing by Resonance Energy Transfer;  Long Wavelength Mutant Fluorescent Proteins;  Use of Promiscuous G-Proteins;  Promiscuous G-Proteins Compositions and Their Use;  Methods and Compositions for Sensitive and Rapid Functional ldentification of Genomic Polynucleotides.

Ultra-high-throughput screening (uHTS) is an automated methodology for conducting hundreds of thousands of biological or chemical screening tests per day using liquid handling devices, sensitive detectors, robotics, data processing, and control software. The results of these experiments provide starting points for drug design and for understanding the interaction or role of a particular biochemical process in biology.

Field of Use
Licensee will undertake screening and development of drug products for the prevention, treatment and diagnosis of diseases and disorders.
Disclaimer: The information gathered from RoyaltySource® database was sourced from the U.S. Securities and Exchange Commission EDGAR Filings and other public records. While we believe the sources to be reliable, this does not guarantee the accuracy or completeness of the information provided. Further, the information is supplied as general guidance and is not intended to represent or be a substitute for a detailed analysis or professional judgment. This information is for private use only and may not be resold or reproduced without permission.